{
  "docId": "019dd923-5fec-763b-95cd-961b6879cda6",
  "docSlug": "njj0K6xhOdjDOAwq28MP",
  "documentTitle": "See the 39-slide presentation that Moderna used to win over investors on its way to becoming the hottest company in biotech",
  "authorId": "Pitchdecks",
  "authorName": "Moderna",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.29,
  "pageNumber": 18,
  "pageCount": 39,
  "prevPage": 17,
  "nextPage": 19,
  "slideType": "solution",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a linear process flow to show how external partners (Charles River, PPD) and internal capabilities (Moderna Norwood) facilitate the development engine.",
  "elementsJson": [
    "action_title",
    "process_diagram",
    "logo_grid"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fec-763b-95cd-961b6879cda6/18",
  "deckHref": "/decks/019dd923-5fec-763b-95cd-961b6879cda6",
  "deckJsonHref": "/decks/019dd923-5fec-763b-95cd-961b6879cda6.json",
  "deckAnchorHref": "/decks/019dd923-5fec-763b-95cd-961b6879cda6#slide-18",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.94,
        "x": 0.03,
        "y": 0.23
      },
      "kind": "callout",
      "text": "Focusing on: Quality » Scalability » Speed » Cost",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "33cf26cb-2612-4efc-a234-e7611bcdfb73",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.88,
        "x": 0.06,
        "y": 0.35
      },
      "kind": "diagram",
      "text": "Moderna Program DC Nomination -> GLP Toxicology (Charles River), Clinical Trials (PPD), GMP Manufacturing (Moderna Norwood) -> Human PoC Data",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bdcae54b-f837-4c57-8fe5-f75706c141d6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.15,
        "x": 0.8,
        "y": 0.88
      },
      "kind": "image",
      "text": "moderna",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ceb3837e-0658-46e7-b145-4c271169c5cc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.06,
        "y": 0.13
      },
      "kind": "title",
      "text": "Moderna's Early Development Engine",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "933a8729-f99f-432e-9462-8652b0267477",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Process flow",
      "slug": "process-flow",
      "agent": null,
      "layer": "slide",
      "matchId": "51d695dc-d689-45eb-a590-6fa55e266714",
      "evidence": "Moderna Program DC Nomination -> GLP Toxicology (Charles River), Clinical Trials (PPD), GMP Manufacturing (Moderna Norwood) -> Human PoC Data",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "value-chain",
      "slug": null,
      "matchId": "e43d2c24-947b-45a8-95c7-1b6d325c18a2",
      "evidence": "The slide maps the sequence of activities and partners involved in the early development process.",
      "confidence": 0.85
    }
  ],
  "arcBeats": [
    {
      "to": 20,
      "from": 14,
      "beatId": "c1aedf83-4c3e-4212-855e-0f80dab7b8c9",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Roadmap",
      "beatSlug": null,
      "evidence": "The presentation outlines Moderna's pipeline and future plans.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}